IL22 and hepatitis A virus infection: Liver-targeted delivery of the IL-22-ApoA1 fusion gene by penetratin-based hybrid nanoparticles relieved liver injury, evaded immune responses, promoted hepatocyte regeneration, and relieved oxidative stress and mitochondrial dysfunction in a concanavalin A-induced hepatitis mouse model [100].